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Abstract
Background—Reliable blood-oxygen-level-dependent (BOLD) fMRI phenotypic biomarkers of
Alzheimer's disease (AD) or mild cognitive impairment (MCI) are likely to emerge only from a
systematic, quantitative, and aggregate examination of the functional neuroimaging research
literature.
Methods—A series of random-effects, activation likelihood estimation (ALE) meta-analyses
were conducted on studies of episodic memory encoding operations in AD and MCI samples
relative to normal controls. ALE analyses were based upon a thorough literature search for all
task-based functional neuroimaging studies in AD and MCI published up to January 2010.
Analyses covered 16 fMRI studies, which yielded 144 distinct foci for ALE meta-analysis.
Results—ALE results indicated several regional task-based BOLD consistencies in MCI and AD
patients relative to normal controls across the aggregate BOLD functional neuroimaging research
literature. Patients with AD and those at significant risk (MCI) showed statistically significant
consistent activation differences during episodic memory encoding in the medial temporal lobe
(MTL), specifically parahippocampal gyrus, as well superior frontal gyrus, precuneus, and cuneus,
relative to normal controls.
Conclusions—ALE consistencies broadly support the presence of frontal compensatory
activity, MTL activity alteration, and posterior midline “default mode” hyperactivation during
episodic memory encoding attempts in the diseased or prospective pre-disease condition. Taken
together these robust commonalities may form the foundation for a task-based fMRI phenotype of
memory encoding in AD.
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Introduction
Associated with the discovery of the blood-oxygen-level-dependent (BOLD) magnetic
resonance (MR) effect, the past two decades are witness to an explosion in research
regarding the functional neuroanatomical correlates of normal memory function. Less
abundant, however, are functional imaging studies examining memory dysfunction in
populations of patients such as those with Alzheimer's disease dementia (hereafter referred
to as AD) and those at higher risk for AD [e.g., mild cognitive impairment (MCI; [1, 2]). To
date, a modest but growing number of AD-related functional magnetic resonance imaging
(fMRI) studies have been conducted tapping episodic memory [3-19], semantic memory
[20-22], implicit memory [6, 12], executive processes [5, 23, 24], and visuospatial abilities
[25, 26]. Also, see Albert et al., 2003 [27]and Lee et al., 2003 [28] for reviews on the
general use of fMRI in MCI. Nevertheless, gleaning a firm consensus within any particular
cognitive domain above has proven difficult due to study-wise differences in imaging
methodologies, task paradigms, and subject characteristics.
Critically, such study-wise differences have contributed to apparently contradictory results
in the research literature. For example, possible MTL compensatory cortical activity during
episodic encoding has been observed in some AD and MCI participant groups relative to
controls [18], yet subsequent researchers have found decreased MTL activation in similar
cortical regions [29]. This discrepancy speaks less to a fundamental problem in our
understanding of the functional MRI (fMRI) correlates of AD and more to the variance in
fMRI task methodologies and subject sample differences across studies. While these
methodological variances are practically unavoidable due to the heterogeneity in study
designs, there may be robust commonalities in task-related fMRI results that reveal
spatially-relevant patterns of brain activation and deactivation. These commonalities may
then be thought of as task-related phenotypic brain activity patterns. This notion of
functional imaging-related phenotypes, while relatively new to the field of age-related
disease research, has been described by researchers within such fields involving disorders of
thought [30, 31], executive control [32-34], and neurodevelopment [35-37]. Establishing
putative MCI- /AD-associated phenotypes via meta-analytic techniques, such as those
employed here, may eventually allow for more targeted intermediate phenotype
(endophenotype) detection, facilitating genetic discovery and streamlining clinical trial
subject selection.
The goal of the current analysis was to determine if such phenotypes could be established by
detectable and consistently robust fMRI patterns. To this end, we chose to focus upon a
cognitive domain tapped by the majority of AD and MCI fMRI studies to date. Episodic
memory encoding, a central function of the declarative memory system [38], represents the
cognitive process involved when an individual is attending to a specific set of novel, event-
or item-based information for memory consolidation and storage for subsequent retrieval or
recognition. Individuals diagnosed with AD and, to a lesser extent, MCI, show notable
changes in episodic memory abilities relative to cognitively normal peers (for a
comprehensive review, see [39]). Deficits in episodic memory encoding and consolidation
are thought to be the primary bases of memory impairment noted in AD and its associated
incipient states [40-42]. The severity of deficits in encoding and consolidation tend to track
closely with the burden of AD-related pathology in the MTL [43]. Thus the MTL has been
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fairly well characterized as the primary regional neuroanatomical correlate of episodic
memory dysfunction in AD. What is less clear is if there are additional regions of
dysfunction in AD and whether consistent spatial patterns of memory-related brain
dysfunction across studies may provide a fMRI BOLD phenotype of AD.
To address these questions, we exhaustively researched the available literature for pertinent
task-based, episodic memory fMRI studies and compared their patient versus normal control
contrast differences using a set of activation likelihood estimation (ALE 2.0; [44]) analyses.
ALE is a permutation-based, meta-analytic imaging approach for interrogating the
likelihood of brain activation pattern overlap from a group of similar functional imaging
study contrasts, and, with the advent of newer iterations of the ALE procedure [45],
statistically significant regional ALE consistencies may be broadly generalized to
populations of interest (i.e., random-effects data analysis). Any statistically significant
spatial patterns to arise from our ALE meta-analyses are hypothesized to reflect aggregate
empirical support for brain regions associated with episodic memory encoding attempts in
MCI and AD patients relative to normal controls, thus providing an example of a consistent
and robust phenotype of task-based BOLD activity in MCI and AD. In sum, the current
analysis extends prior research by using a random-effects, coordinate-based, spatial
activation estimation analysis (ALE), providing a rigorous, conservative empirical
examination of common regions of fMRI/BOLD activation in MCI and AD patients relative
to normal elder controls.
Methods
An initially broad and thorough literature search was conducted focusing on studies that
employed functional neuroimaging in MCI and AD participant groups. The literature search
was conducted on the Medline/PubMed databases using the following National Library of
Medicine MesH term algorithm: [(Magnetic Resonance Imaging OR positron emission
tomography) AND (Alzheimer Disease OR Amnesia OR Cognition Disorders) AND
(Humans) AND (middle age OR aged OR (aged, 80 and over)]. This search was confined to
articles published between 1980/01/01 and 2009/12/31, which yielded 2719 unique research
or review manuscripts. From these research articles we examined and considered only those
that had group-related task contrasts tapping aspects of declarative memory in AD and MCI
patient samples relative to normal elderly participants, which significantly narrowed the
original pool to 81 studies. Divided by imaging modality, 62 of these studies were
conducted using fMRI, and the remaining 19 used positron emission tomography (PET)
during performance of a cognitive task paradigm. For the current meta-analyses, only
articles that reported fMRI contrasts of task components involving episodic memory
encoding (i.e., face-name encoding, novel vs. familiar encoding, etc.) were considered for
analysis – yielding a total of 38 studies published between 2003 - 2009. For entry into the
planned ALE meta-analyses [44, 45], a procedure successfully implemented in several
recent functional imaging reviews of episodic memory function [46-48], it was also
necessary that studies referenced significant group-wise contrast results in a standardized
neuroanatomical spatial coordinate system, either Talairach or MNI space. Ten studies from
the pool of 38 were excluded due to lack of reported brain atlas coordinates. Studies were
also excluded if subjects were healthy but only genetically at-risk for Alzheimer's disease
(e.g., APOEε4) and did not evince cognitive symptoms (7 studies), or if the studies
primarily involved pharmacological fMRI effects, without baseline comparisons of MCI or
AD patients (5 studies). A final set of 16 studies remained with a publication date range
from 2003 to 2009 (see Table 1).
One hundred and forty-four distinct spatial foci from 30 different group-wise episodic
memory encoding contrasts served as the primary data for the planned series of ALE
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metaanalyses [44]. Four separate ALE analyses were conducted to interrogate the
directionality of episodic memory encoding activity differences in MCI and AD patients
relative to controls. AD-related ALE analyses examined contrast foci associated with greater
encoding-related activation in AD patients relative to elder controls (8 contrasts, 42 foci)
and reduced activation in AD patients relative to controls (10 contrasts, 52 foci); while MCI
analyses examined contrast foci associated with greater activation in MCI participants
relative to elder controls (4 contrasts, 22 foci) and less activation in MCI than controls (8
contrasts, 28 foci). Group comparisons and task paradigms with corresponding foci are
presented in Table 1.
Task paradigms with episodic memory encoding components of varied somewhat across the
included studies. Of the 16 studies analyzed, eight different types of paradigms were
represented (N.B., the “fMRI Task Paradigm” column in Table 1 denotes the task type used
to obtain group-wise comparison of episodic memory encoding activity). One particularly
prevalent paradigm among the studies identified is a face/name paired-associative learning
task adapted from Sperling et al. [49]. In this task, participants are shown blocks of stimuli
in which a novel or familiar face is paired with a name. In a later run, participants are again
shown the stimuli and asked whether the correct name is matched with the correct face. In
some of the studies participants were asked to give an initial subjective determination of
whether the name “fit” the face. Other studies (Table 1, nos. 4 and 12) did not use a name
component but simply presented unfamiliar faces and asked participants to encode them for
later recall during a subsequent recognition task [8, 17]. Other variants of discrimination
between novel and repeated stimuli were represented in the selected studies. Golby and
colleagues asked participants to remember whether or not they had previously viewed a
particular visual scene [6], while Kircher et al. used verbal rather than visual stimuli and
instructed participants to encode words that would be recalled in a subsequent memory test
[11].
In addition to task variation, the studies included in the current ALE analyses differed in
their classification methods for MCI or AD. All AD patients from the included studies were
classified as having probable AD of mild to mild-to-moderate severity based on NINCDS-
ADRDA diagnostic criteria [50]. Most studies relied upon Clinical Dementia Rating scale
(CDR; [51] or the Mini-mental Status Exam (MMSE; [52]) scores as the primary measures
of functional and cognitive decline, respectively. Although these measures were not the sole
criterion for diagnostic classification, they provide a general indication of the extent of
cognitive impairment among the participants in the included studies. AD patients in the
included studies had mean MMSE scores ranging from 20.8 to 26.33, while the range of
mean MMSE scores among the MCI participants was characteristically higher (i.e., 25.3 to
28.4; see Table 1). CDR totals were consistent with suggested guidelines for functional
impairments suggestive of AD or MCI (i.e., AD ≥ 1, MCI = 0.5). In addition to the MMSE
and CDR, MCI participants from the included studies were further classified based on
cognitive assessments, the results of which suggested comparative mild weaknesses in
memory performance and possibly another cognitive domain in line with established MCI
classification criteria [53].
To allow for direct comparison of brain spatial coordinates across studies, transformations
were required to bring all contrast foci to a common atlas space. Spatial coordinates reported
by the included studies in Montreal Neurological Institute (MNI) space were transformed to
Talairach atlas space [54] using the Lancaster “icbm2tal” transform [55]. Specialized
versions of the Lancaster transform were used to account for spatial transformation
differences among the various imaging analysis platforms (e.g. icbm_spm2tal). Coordinates
that had already undergone the Brett transform [56] from MNI to Talairach space before
publication were treated differently. Brett transform Talairach foci coordinates were
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converted back to MNI atlas space using a reverse transform algorithm, after which these
coordinates were then returned to Talairach space using the aforementioned Lancaster
transform [55]. After all study coordinates were transformed similarly to common Talairach
space, the four ALE meta-analyses were performed [44].
Activation likelihood estimate (ALE) analyses were conducted for each directional contrast
(AD/MCI > control and AD/MCI < control) by modeling each reported study foci as a three-
dimensional Gaussian function smoothed with a 12 millimeter (mm) full width half
maximum (FWHM) kernel [57] to allow enough spatial overlap among foci for statistical
comparison. Statistical significance was evaluated using the standard ALE permutation
procedure with a minimum of 5000 permutations per solution. ALE analyses were corrected
for multiple comparisons using a false discovery rate procedure (FDR; [44, 58] and
thresholded for cluster size to conservatively control for Type I error. To exceed established
analysis thresholds, ALE analysis clusters were required to be statistically significant at
FDR q < .05 with a minimum volume of 100 mm3, and to be considered “phenotypic,” ALE
analysis clusters were required to have contributing spatial coordinates from a minimum of
at least two independent studies from Table 1. The resulting ALE coordinates for clusters
surviving these analysis thresholds were then reconverted back to MNI atlas space using the
Lancaster transform [55]. Additionally, for visualization purposes the resulting ALE image
maps were warped from Talairach atlas space to MNI space (see Figure 1 & Supplemental
Figures) using SPM8 (Wellcome Institute, UK) non-linear warp transformation.
Results
Peak MNI coordinates, Brodmann areas, and cluster sizes for significant ALE regional
commonalities are summarized in Table 2. The ALE values noted in Table 2 are the
maximum activation likelihood estimates for individual statistically significant clusters. All
ALE values are significant based on a False Discovery Rate (FDR) of q < .05; k ≥ 100mm3.
Thresholded ALE spatial maps for regions of common difference between AD or MCI
patients and controls during episodic memory encoding are presented in Fig. 1. Brain
regions where encoding-related activation tends to be greater in MCI individuals relative to
elder controls are shown in red, while regions where relative activation was greater in
controls than in MCI patients are denoted in green (Figure 1, Section A). A single common
cluster in the right anterior parahippocampal gyrus (∼BA 35 region; 25x,-15y,-14z)
survived ALE analysis of study contrasts where activity was greater in MCI relative to
control participants. Conversely, two regions survived ALE statistical thresholding where
activity was less in MCI patients relative to controls. One such focus was in the right
anterior parahippocampal gyrus, similar to the MCI > control ALE results, though more
posterior along the hippocampal axis (∼BA 28 region; 27x,-27y,-11z), and the other focus
in the left inferior frontal gyrus region (BA 9; -46x,11y,31z).
Significant common spatial foci for task-based, episodic memory BOLD activation/
deactivation in AD patients relative to controls are shown in Figure 1, Section B. Blue
regions indicate areas of greater activation in AD patients, while yellow foci indicate greater
activation in controls. Robust ALE regions in AD patients relative to controls were in the
bilateral posterior midline [i.e., right precuneus (BA 31; 10x,-66y,29z), left precuneus (BA
31; -11x,-64y,33z), and left cuneus (BA 18; -16x,-72y,18z)], right superior temporal gyrus
(BA 41; 53x,-30y,4z) and left superior frontal gyrus (BA 6/8; -24x,40y,43z). Control
relative to AD regions lied in the anterior cerebellum (5x,-48y,-31z), right anterior
parahippocampal gyrus (∼BA 28; 18x,-17y,-23z), and right lingual gyrus (BA 19; 32x,-75y,
2z).
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Other smaller ALE analysis clusters are revealed when analyses are run with less
conservative statistical and extent thresholds, but the regional commonalities reported above
reflect the most robust findings across studies lending support to common phenotypic fMRI
activation pattern associated with AD (and to a lesser extent, MCI). Therefore, the reported
results reflect conservative estimates of commonly observed phenotypic differences in the
functional neuroanatomical substrates governing episodic encoding between MCI or AD
subjects and normal elder controls. Broadly, MCI and AD subjects both show a marked
decrease in BOLD activation during episodic memory encoding in the right anterior
parahippocampal region (∼BA 28), while encoding-related BOLD patterns differentiate
between patient and controls in terms of the relative activation of other MTL structures,
dorsolateral prefrontal cortex and posterior midline regions during episodic memory
encoding.
Supplemental figures 2, 3, 4, and 5 illustrate the spatial positions of foci maxima for the
various episodic memory-related task contrasts that contributed to the composite ALE
findings given in figure 1 (Sections A & B). Figure 2 shows the spatial locations of
increased BOLD activity contrast maxima for elder controls relative to MCI patients. Red
coordinates indicate areas where encoding certain stimuli (objects, scenes, spatial locations,
or faces) elicited a significant increase in BOLD activity from baseline, while blue foci
indicate increased activation for novel versus repeated stimuli and green foci show areas of
increased activation for successful memory encoding in normal patients relative to MCI.
Conversely, supplemental figure 3 reveals the spatial locations for increased activation in
MCI patients versus normal controls during simple encoding greater than baseline contrasts
(red) and remembered versus forgotten (i.e. successful memory encoding) task paradigms
(green). Supplemental figures 4 and 5 illustrate similar contrast differences by episodic
memory task type between AD patients and normal controls.
Discussion
Numerous functional imaging investigations examining the neural substrates underlying
AD-related memory decline have yielded a substantial body of literature on the subject;
however, the diversity across experimental paradigms has made it difficult to draw
consistent inferences from these findings [27, 28]. By amassing results of studies focused on
a single component of memory (episodic encoding) and performing a series of ALE meta-
analyses on the available fMRI data, it is possible to spatially illustrate statistically
significant concordant findings. The results of these aggregate analyses highlight consistent
functional neuroanatomical regions important to episodic memory dysfunction in individuals
with AD and those at significant risk (MCI). They also model an empiric approach capable
of consolidating the results of multiple studies across a variety of institutions, scanner types
and patient samples.
The anterior parahippocampal gyrus, at approximately the BA 28 region (entorhinal cortex),
demonstrated consistently decreased activation in both AD and MCI patients versus control
subjects across the studies used in the current ALE analyses. Such results are in-line with
volumetric studies documenting decreased entorhinal volume in MCI and AD. For example,
Du and colleagues [59] reported that entorhinal cortex and hippocampal volumes were
significantly reduced in MCI (entorhinal cortex 13%, hippocampus 11%) and AD
(entorhinal cortex 39%, hippocampus 27%) compared with NC. Furthermore, AD showed
greater volume losses in the entorhinal cortex than in the hippocampus. Taken together,
these findings suggest that volumetric and functional reductions in anterior parahippocampal
cortex (∼BA28) play an important role in the episodic encoding impairments observed in
MCI and AD. Of note, none of the studies considered accounted for the possible effects of
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atrophy on activation in the medial temporal lobe [60, 61], and therefore it is not possible to
disentangle these two effects on the basis of our results.
Another region along the anterior parahippocampal gryus, approximately in BA 35
(perirhinal cortex), demonstrated greater activity in MCI than control individuals. Although
there have been extensive discussions about the role of the perirhinal cortex in episodic
memory (see [62]for recent review), one prominent view is that perirhinal activity is
associated with processing episodic familiarity signals [63]. Studies in healthy young
individuals have documented enhanced perirhinal activity during encoding [64] and retrieval
[65] of “unitized” information (e.g., a background color of a studied word or features of a
face), leading to the proposal that perirhinal cortex may encode feature-fused item
representations that can support later source judgments on the basis of stimulus familiarity
[64, 66, 67]. However, over reliance on stimulus familiarity during encoding can lead to
high levels of memory errors, and under such conditions, significantly greater activity
during false than during accurate retrieval has been reported in the perirhinal cortex in older
adults [68]. Such findings suggest that the anterior parahippocampal activity (at
approximately BA35) observed in the current analysis may reflect an increase or over
reliance on familiarity-based processing during episodic encoding in MCI, not necessarily
beneficial to successful memory.
Another strong ALE finding was apparent in the comparison of study contrasts involving
greater activity in AD patients relative to controls. Precuneus and cuneus activation is
particularly robust across contrasts of this type, and are regions known to be part of a
“default network” associated with intrinsic baseline activity in the brain, and physiologically
normal deactivation during a wide variety of tasks, including memory encoding [69]. The
consistent observation of greater activation in these regions in AD patients compared to
controls reinforces an aberration in the ability to effectively redistribute cognitive resources
during memory tasks, perhaps indicating a functional breakdown in precuneus/cuneus
connectivity in AD/MCI patients. A distinct pattern of abnormally high activity in the
default network has been consistently found in AD and MCI patients when compared to
healthy controls [70]. In fact, this finding is often consistent enough as to be able to
discriminate AD patients from healthy controls based on default network activation with a
sensitivity of 85% [71]. Thus our findings support a similarly strong phenotypic dysfunction
of cuneus/precuneus BOLD activation during memory task performance in AD patients,
which is consistent with recent findings that strong posterior midline activation during
memory task performance is a negative predictor of memory encoding success [72].
Increased activation in left superior frontal gyrus for both MCI or AD versus normal
controls, an area known to be important in memory encoding and retrieval, suggests that
both patient types tend to engage in their respective memory tasks. Prefrontal lobe activation
is observed in AD patient relative to controls, but the activation locus tends to be smaller
and more superior to the MCI aggregate ALE result locus. This general reduction in
prefrontal lobe activation for AD versus control studies may suggest some variably in task
attention between AD versus control studies.
Our analyses also reveal a robust increase in pre-frontal activity during encoding tasks for
both AD and MCI patients versus controls. This finding points to the PFC as a possible
compensatory mechanism for patients with lower than normal activity in traditional memory
networks (i.e. entorhinal cortex). For example, a shift from medial temporal- to frontal-
based processing has been documented previously in healthy older adults during episodic
encoding [73] and episodic retrieval [74]. In those studies, significant correlations were
obtained between decreased medial temporal lobe activity and increased prefrontal activity
during accurate performance, and the results interpreted to reflect compensatory processes
Browndyke et al. Page 7













whereby prefrontal regions are recruited to counteract neurocognitive decline in the context
of deficient medial temporal lobe memory system function. The current findings indicate
that a similar shift from medial temporal lobe to prefrontal regions occurs in populations
with frank episodic encoding impairments.
Schwindt and Black [47] conducted a similar quantitative ALE meta-analysis of fMRI
studies involving episodic memory dysfunction. In alignment with our results, they
confirmed a decrease in MTL activity during episodic memory tasks in AD patients. Their
general results for areas of increased activity in AD patients matched our results as well,
including activation in the pre-frontal cortex, parietal lobe, cuneus, and superior temporal
gyrus. However, there are several factors that differentiate our results. For example, their
study focused on results from AD patients only, excluding findings from subjects with
milder forms of cognitive impairment likely reflecting prodromal Alzheimer's disease. In
contrast, the present study provides a basis for examining the regional consistency of task-
related BOLD activity along a spectrum of cognitive disorder from normal controls to MCI
to AD. Additionally, our analysis included only those studies that reported data for both
cognitively impaired patients and healthy controls, allowing us to isolate patterns of
common difference and reducing the heterogeneity of these patterns. Conversely, Schwindt
and Black included some studies with data of AD patients only (without a control
comparison). Their study also included PET data in the meta-analysis. However, since there
tends to be variability between fMRI and PET results, we elected not to include PET studies
to elucidate more refined activity patterns specific to task-related BOLD. Additionally, in
contrast to the Schwindt and Black analyses, we opted not to include fMRI BOLD studies in
our analyses that primarily involved pharmacological interventions for AD. A few of the
studies included in our analyses noted pharmacological treatment of AD patients, which are
noted in Table 2, but these treatments were not the focus of the included studies and were
limited to standard acetylcholinesterase inhibition approaches. Methodologically, an
important distinguishing factor of the present study is its implementation of the ALE meta-
analysis technique amenable to random-effects inference of the results. Previous ALE
analyses (including the one conducted by Schwindt and Black) used a fixed-effects ALE
analysis that tested for above-chance clustering between foci. However, the current results
assessed for random-effects clustering between experiments; thus our results may be more
generalized to the population of task-based BOLD studies of MCI and AD.
To be considered “phenotypic,” ALE analysis clusters were required to have contributing
spatial coordinates from a minimum of at least two independent studies from Table 1.
However, significant regions actually reflect a much greater contribution from multiple
independent studies. For example, in the comparison of activity greater for AD participants
than for controls participants, contributing spatial coordinates from right precuneus (BA 31)
were observed in four of the studies (i.e., Gould, et al., 2005 [7]; Pariente et al., 2005 [13];
Petrella, et al., 2007 [70]; and Sperling, et al., 2003 [18]), reflecting the same observation
from independent research groups and distinct patient samples. Similarly, the reduced
activity during episodic memory encoding in the right anterior parahippocampal gyrus of
MCI participants relative to controls (∼BA 28) was also detected in four independent
studies [8-10, 19]. It should be noted, however, that the notion of task-based fMRI
phenotypes for episodic memory encoding applies only to each patient group separately. The
relationship between MCI, dementia, and AD has yet to be fully elucidated, and often,
depending upon the diagnostic criteria selected, MCI may or may not reflect incipient AD.
Therefore any significant ALE regions from the analyses represents contrasts between AD
or MCI patients and elder controls, not a direct contrast between AD and MCI patients. A
potential source of bias in our ALE results is the use of varied paradigms to investigate
episodic encoding. A majority of the studies included for analyses used visual memory
paradigms, which likely accounts for the greater emphasis of right hemispheric common
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differences; particularly those noted in the MTL region. The face-name associative encoding
task developed by Sperling et al. [49] was particularly well represented, while remaining
studies tended to use verbal encoding tasks involving recall of word lists. Although we
grouped visual and verbal studies together in the ALE analysis, the results are heavily
weighted towards visual episodic encoding (hence the consistent right MTL activation foci
in both patient groups).
Our analysis of the episodic encoding component of memory using ALE gives us an
interesting new perspective on possible MCI and AD task-based BOLD phenotypes. More
specifically, our analysis suggests a robust imaging phenotype in Alzheimer's dementia and
MCI confined to the MTL, specifically the parahippocampal gyrus, as well superior frontal
gyrus, precuneus, and cuneus. The locality of these consistent task-based fMRI signatures
appears to support current research about the effect of AD pathogenesis on functional
network connectivity. For example, Sperling and her colleagues postulate that the initial
hyperactivity observed in the MTL during episodic encoding in MCI may be secondary to
this region becoming progressively more functionally “disconnected” from the rest of the
papez circuit and PCG region [75]. This general pattern of episodic memory functional
network disruption appears to fit with the current ALE analyses results - when MTL
functioning begins to fail secondary to AD neuropathological changes, patients may rely
more upon self-referential information search (i.e., PCG activity) during memory encoding
and retrieval attempts [76]. Consistent findings of coincident PFC activity in AD patients
during memory task performance indicates that the PCG activity is not likely to just be a
byproduct of their not trying during the task.
More research is needed particularly in early prodromal AD to better understand the extent
to which the current findings in MCI reflect early Alzheimer's disease traits, but the
consistent robustness of ALE activation commonalities in the MTL and PCG certainly
highlights these regions as being central to any future functional neuroimaging studies of
AD pathogenesis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Common, regional blood-oxygen-level-dependent (BOLD) activation differences during
episodic memory encoding in MCI or AD persons relative to normal elder controls.
Note: A.) MCI relative to normal controls. ALE meta-analysis of 12 experimental contrasts
(50 foci) with a statistical significance threshold of FDR q < .05, kextent ≥ 100 mm3, and
requirement of contributing coordinates from at minimum of two independent studies from
Table 1. Red foci = MCI < Control; Green foci = MCI > Control.
B.) AD relative to normal controls. ALE meta-analysis of 18 experimental contrasts (94
foci) with a statistical significance threshold of FDR q < .05, kextent ≥ 100 mm3, and
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requirement of contributing coordinates from at least two independent studies from Table 1.
Yellow foci = AD < Control; Blue foci = AD > Control.
Neurological representation slices in-plane with statistically-significant ALE foci, visualized
on a single-subject, ICBM Montreal Neurological Institute atlas space brain (MNI; [81]).
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